Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Fairfax Financial Holdings Ltd T.FFH

Alternate Symbol(s):  FRFHF | T.FFH.PR.C | FXFLF | FRFZF | T.FFH.PR.D | FRFGF | T.FFH.PR.E | FXFHF | T.FFH.PR.F | FAXRF | T.FFH.PR.G | FAXXF | T.FFH.PR.H | FRFXF | T.FFH.PR.I | T.FFH.PR.J | T.FFH.PR.K | FRFFF | T.FFH.PR.M | FFHPF

Fairfax Financial Holdings Limited is a Canada-based holding company. The Company, through its subsidiaries, is engaged in property and casualty insurance and reinsurance and the associated investment management. The Company’s segments include Property and Casualty Insurance and Reinsurance, Life insurance and Run-off and Non-insurance companies. The Property and Casualty Insurance and... see more

TSX:FFH - Post Discussion

View:
Post by retiredcf on Nov 07, 2022 10:00am

RBC 2

Their upside scenario target is US$975.00. GLTA

November 4, 2022
Fairfax Financial Holdings Limited

Strong underwriting, improving investing returns drive solid 3Q results

Our view: Core underwriting margins continue to improve and investment income is steadily rising as cash is deployed. Associate and non-insurance operations are also improving contributing additional operating income. Fairfax is delivering good results in all areas of the business and is in a very strong financial position. We think this has been an overlooked story and while the business remains complex, at 85% of book value it is trading at such a significant discount to peers it deserves a fresh look. We remain at Outperform.

Key points:

Adjusting estimates: We are raising our 2022 net income estimate to $21.50 from $(23.61) which reflects the results in the quarter, higher operating income and a $42 realized gain on the sale of the Pet business. We’ve raised our 2023 estimate to $95.75 from $78.75 reflecting higher investment income and moderately better underwriting margins associated with still strong underwriting conditions. We initiate a 2024 estimate of $100.00. On an operating basis we are raising our estimate to $68.91 from $49.04 for 2022 reflecting the upside in the quarter, better underwriting margins and higher associate and investment income. Our 2023 estimate rises to $82.33 from $65.43 reflecting similar factors, and we initiate a 2024 operating EPS estimate of $86.58.

Price target: Our target remains $700 (about C$950 at a 1.35:1 exchange rate). This remains based on approximately 1.0x book value which we apply to ending 2023 book.

3Q results: Reported 3Q22 net loss per share of $3.65 vs. earnings of $16.44 last year and our $(11.79) estimate. On an operating basis, the company earned $14.92 per share (RBC forecast was $2.97). Results reflect  better than forecast underwriting income as well as upsides in investment  income, profit from associates and non-insurance company income.

Items of note: It was another strong quarter for premium growth with the company’s largest units. Odyssey was particularly impressive up 27%. The overall combined ratio amounted to 100.3% vs. 101.1% which beat our 101.6% forecast. Total cat losses were $803 million or 15 combined ratio points. The company closed its sale of Crum’s pet insurance business in October which will result in a $992 million after tax gain in 4Q (we’ve included this in our estimates since it is known). Buybacks in the quarter totaled about 209,000 shares (about $110 million).

Positives: 1) Excellent underlying combined ratio fo 86.2%; 2) Strong premium growth; 3) rising investment income.

Negatives: 1) 
Higher than expected cat losses; 2) loss on acquisition of Allied World shares; 3) adverse portfolio marks impact book value.

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities